CPT codes

55081 CPT codes with hospital pricing data in the network.

• CPT 0539U — Oncology (solid tumor), cell-free circulating tumor DNA (ctDNA), 152 genes, next-generation sequencing, interrogation for single-nucleotide variants, insertions/deletions, gene rearrangements (215 hospitals, — samples)
• CPT 0540T — HC CAR T-CELL REINFUSION (193 hospitals, — samples)
• CPT 0540U — Transplantation medicine, quantification of donorderived cell-free DNA using next-generation sequencing analysis of plasma, reported as percentage of donor-derived cell-free DNA to determine (215 hospitals, — samples)
• CPT 0541T — Myocardial imaging by magnetocardiography (MCG) for detection of cardiac ischemia, by signal acquisition using minimum 36 channel grid, generation of magnetic-field time-series images, quantitative an (350 hospitals, — samples)
• CPT 0542T — Myocardial imaging by magnetocardiography (MCG) for detection of cardiac ischemia, by signal acquisition using minimum 36 channel grid, generation of magnetic-field time-series images, quantitative an (243 hospitals, — samples)
• CPT 0543T — TRANSAPICAL MV RPR W/TTE PLMT ARTIF CHORDAE TEND (359 hospitals, — samples)
• CPT 0543U — Oncology (solid tumor), next-generation sequencing of DNA from formalin-fixed paraffinembedded (FFPE) tissue of 517 genes, interrogation for single-nucleotide variants, multinucleotide variants (224 hospitals, — samples)
• CPT 0544T — Tcat mv annulus rcnstj (344 hospitals, — samples)
• CPT 0545T — HC TCAT TV ANN RCNSTJ W/IMPL ADJST ANN RCNSTJ DEV (369 hospitals, — samples)
• CPT 0545U — Acetylcholine receptor (AChR), antibody identification by immunofluorescence, using live cells, reported as positive or negative (198 hospitals, — samples)
• CPT 0546U — Low-density lipoprotein receptor-related protein 4 (LRP4), antibody identification by immunofluorescence, using live cells, reported as positive or negative (215 hospitals, — samples)
• CPT 0547T — Bone-material quality testing by microindentation(s) of the tibia(s), with results reported as a score (270 hospitals, — samples)
• CPT 0547U — Neurofilament light chain (NfL), chemiluminescent enzyme immunoassay, plasma, quantitative (198 hospitals, — samples)
• CPT 0548T — TRANSPERINEAL PERIURETHRAL BALLOON CONTINENCE DEVICE; BILATERAL PLACEMENT, INCLUDING CYSTOSCOPY AND FLUOROSCOPY (80 hospitals, — samples)
• CPT 0548U — GFAP CLEIA PLASMA (198 hospitals, — samples)
• CPT 0549T — TRANSPERINEAL PERIURETHRAL BALLOON CONTINENCE DEVICE; UNILATERAL PLACEMENT, INCLUDING CYSTOSCOPY AND FLUOROSCOPY (78 hospitals, — samples)
• CPT 0549U — Oncology (urothelial), DNA, quantitative methylated real-time PCR of TRNA-Cys, SIM2, and NKX1-1, using urine, diagnostic algorithm reported as a probability index for bladder cancer (215 hospitals, — samples)
• CPT 0550T — Fee Schedule (55 hospitals, — samples)
• CPT 0551T — TRANSPERINEAL PERIURETHRAL BALLOON CONTINENCE DEVICE; ADJUSTMENT OF BALLOON(S) FLUID VOLUME (55 hospitals, — samples)
• CPT 0553T — OP Surgery (208 hospitals, — samples)
• CPT 0553U — Repr med pga embry te strux (208 hospitals, — samples)
• CPT 0554T — BONE STRENGTH & FRACTURE RISK ANALYSIS (216 hospitals, — samples)
• CPT 0554U — Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from trophectoderm biopsy for aneuploidy, ploidy, a mitochondrial DNA score (208 hospitals, — samples)
• CPT 0555U — Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using DNA genomic sequence analysis from embryonic trophectoderm for structural arrangements (208 hospitals, — samples)
• CPT 0556U — Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific DNA and RNA by real-time PCR, 12 targets, nasopharyngeal or oropharyngeal swab, including multiplex reverse (197 hospitals, — samples)
• CPT 0557T — BONE STRENGTH & FRACTURE RISK I&R (215 hospitals, — samples)
• CPT 0557U — Infectious disease (bacterial vaginosis and vaginitis), realtime amplification of DNA markers for Atopobium vaginae, Gardnerella vaginalis, Megasphaera types 1 and 2, bacterial vaginosis associated (197 hospitals, — samples)
• CPT 0558T — Computed tomography scan taken for the purpose of biomechanical computed tomography analysis (357 hospitals, — samples)
• CPT 0558U — Oncology (colorectal), quantitative enzyme-linked immunosorbent assay (ELISA) for secreted colorectal cancer protein marker (BF7 antigen), using serum, result reported as indicative of response (197 hospitals, — samples)
• CPT 0559U — Onc brs quan elisa bf9ag srm (197 hospitals, — samples)
• CPT 0560U — Oncology (minimal residual disease ºMRD»), genomic sequence analysis, cell-free DNA, whole blood and tumor tissue, baseline assessment for design and construction of a personalized variant panel to (207 hospitals, — samples)
• CPT 0561U — Oncology (minimal residual disease ºMRD»), genomic sequence analysis, cell-free DNA, whole blood, subsequent assessment with comparison to initial assessment to evaluate for MRD (207 hospitals, — samples)
• CPT 0562U — ONC SOL TUM TGSA 33GENS SNVS (197 hospitals, — samples)
• CPT 0563T — Evacuation of meibomian glands, using heat delivered through wearable, open-eye eyelid treatment devices and manual gland expression, bilateral (389 hospitals, — samples)
• CPT 0563U — Infectious disease (bacterial and/or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 11 viral targets and 4 bacterial targets, qualitative RT-PCR, upper respi (210 hospitals, — samples)
• CPT 0564U — Infectious disease (bacterial and/or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 10 viral targets and 4 bacterial targets, qualitative RT-PCR, upper respiratory sp (210 hospitals, — samples)
• CPT 0565T — Autologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; tissue harvesting and cellular implant creation (337 hospitals, — samples)
• CPT 0565U — Oncology (hepatocellular carcinoma), next-generation sequencing methylation pattern assay to detect 6626 epigenetic alterations, cellfree DNA, plasma, algorithm reported as (197 hospitals, — samples)
• CPT 0566T — AUTOL CELL IMPLT ADPS TISS NJX IMPLT KNEE UNI (350 hospitals, — samples)
• CPT 0566U — Oncology (lung), qPCRbased analysis of 13 differentially methylated regions (CCDC181, HOXA7, LRRC8A, MARCHF11, MIR129-2, NCOR2, PANTR1, PRKCB, SLC9A3, TBR1_2, TRAP1, VWC2, ZNF781), pleural fluid, (197 hospitals, — samples)
• CPT 0567T — Perm flp tube occls w/implt (214 hospitals, — samples)
• CPT 0567U — Rare diseases (constitutional/heritable disorders), whole-genome sequence analysis combination of short and long reads, for single-nucleotide variants, insertions/deletions and characterized intronic (197 hospitals, — samples)
• CPT 0568T — Fee Schedule (222 hospitals, — samples)
• CPT 0568U — Neurology (dementia), beta amyloid (A?40, A?42, A?42/40 ratio), tau-protein phosphorylated at residue (eg, pTau217), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP), (197 hospitals, — samples)
• CPT 0570U — Neurology (traumatic brain injury), analysis of glial fibrillary acidic protein (GFAP) and ubiquitin carboxylterminal hydrolase L1 (UCHL1), immunoassay, whole blood or plasma, individual components (227 hospitals, — samples)
• CPT 0571U — Onc sol tum dna80&rna10g ngs (197 hospitals, — samples)
• CPT 0575U — Transplantation medicine (liver allograft rejection), miRNA gene expression profiling by RT-PCR of 4 genes (miR-122, miR-885, miR-23a housekeeping, spike-in control), (192 hospitals, — samples)
• CPT 0576U — Transplantation medicine (liver allograft rejection), quantitative donor-derived cell-free DNA (cfDNA) by whole genome nextgeneration sequencing, (192 hospitals, — samples)
• CPT 0577U — Oncology (ovarian), serum, analysis of 39 glycoproteins by liquid chromatography with tandem mass spectrometry (LC-MS/MS) in multiple reaction (203 hospitals, — samples)
• CPT 0578U — ONC CUTAN MLN RNA QPCR 10GEN (193 hospitals, — samples)